Abstract: This disclosure concerns a new method for preparing radioisotopes, such as molybdenum-99, by alpha particle irradiation, such as by alpha particle irradiation of zirconium-96. Molybdenum-99 is a precursor to the medically-significant radioisotope technetium-99m. Also disclosed are novel compositions containing one or more of technetium-99m, molybdenum-99 and zirconium species. Systems for producing molybdenum-99 and technetium-99m, including alpha particle generators and irradiation targets, also are described.

Abstract: Medical isotope generator systems are disclosed according to some aspects. In one aspect, a 90Y generator system comprises a generator column, a concentration column, and a flow control system, through which the generator column and the concentration column are in fluid communication. The flow control system provides a plurality of flow configurations for delivering a milking solution to the generator column, the concentration column, or both, and for delivering an eluent solution to the concentration column in either a forward or a reverse flow direction. The generator column can comprise a 90Sr stock adsorbed on a sorbent. The milking solution preferentially elutes 90Y from the generator column. The concentration column comprises a sorbent that captures 90Y from the milking solution without altering the milking solution. The eluent solution elutes 90Y from the concentration column.

Abstract: This disclosure concerns a new method for preparing radioisotopes, such as molybdenum-99, by alpha particle irradiation, such as by alpha particle irradiation of zirconium-96. Molybdenum-99 is a precursor to the medically-significant radioisotope technetium-99m. Also disclosed are novel compositions containing one or more of technetium-99m, molybdenum-99 and zirconium species. Systems for producing molybdenum-99 and technetium-99m, including alpha particle generators and irradiation targets, also are described.

Abstract: Medical isotope generator systems are disclosed according to some aspects. In one aspect, a 90Y generator system comprises a generator column, a concentration column, and a flow control system, through which the generator column and the concentration column are in fluid communication. The flow control system provides a plurality of flow configurations for delivering a milking solution to the generator column, the concentration column, or both, and for delivering an eluent solution to the concentration column in either a forward or a reverse flow direction. The generator column can comprise a 90Sr stock adsorbed on a sorbent. The milking solution preferentially elutes 90Y from the generator column. The concentration column comprises a sorbent that captures 90Y from the milking solution without altering the milking solution. The eluent solution elutes 90Y from the concentration column.

Abstract: A method for purifying Y-90 from a Sr-90/Y-90 "cow" wherein raw Sr-90/Y-90 source containing impurities is obtained from nuclear material reprocessing. Raw Sr-90/Y-90 source is purified to a fresh Sr-90/Y-90 source "cow" by removing impurities by addition of sodium hydroxide and by removing Cs-137 by further addition of sodium carbonate. The "cow" is set aside to allow ingrowth. An HDEHP organic extractant is obtained from a commercial supplier and further purified by saturation with Cu(II), precipitation with acetone, and washing with nitric acid. The "cow" is then dissolved in nitric acid and the purified HDEHP is washed with nitric acid and scrubbed with either nitric or hydrochloric acid. The dissolved "cow" and scrubbed HDEHP are combined in an organic extraction, separating Y-90 from Sr-90, resulting in a Sr-90/Y-90 concentration ratio of not more than 10(E-7), and a metal impurity concentration of not more than 10 ppm per curie of Y-90. The separated Y-90 may then be prepared for delivery.

Abstract: There is disclosed a process for minimally derivatizing a targeting protein with a radionuclide such that the predominant species of derivatized targeting protein contains one radionuclide group as a single radiolabeled ligand, and whereby the binding characteristics of the targeting protein are minimally affected. There is further disclosed ligands that can chelate a metal radionuclide or bind a halogen radionuclide while providing a means for separating radiolabeled ligand from unradiolabeled ligand.

Abstract: A novel method for the production of bis(arene) technetium radiodiagnostic imaging agents is herein disclosed. The method consists of employing Fischer synthesis reactants in an ultrasonic bath. The products are virtually pure, thus lacking the severe degree of disproportionation which routinely occurs when partially alkylated bis(arene)technetium compounds are produced by thermally driven reactions.

Abstract: A cationic Tc-99m-arene complex, useful as a myocardial perfusion imaging agent, is produced by reacting a Tc compound in an oxidation state higher than I with benzene or substituted benzene in the presence of a reducing agent and a metal halide which is capable of withdrawing halide ions.

Abstract: Novel technetium [99m](I) complexes useful as imaging agents.